52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -4.49 % |
3 Month Return | -40.08 % |
1 Year Return | -76.49 % |
Market Stats | |
Previous Close | ₹6.07 |
Open | ₹5.95 |
Volume | 1.35L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹244.74Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹244.74 Cr |
P/B Ratio | 2.55 |
EPS | 0 |
Dividend Yield | 0 |
Sector | Trading |
ROE | 122.77 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹244.74 Cr | 575% | 0.79 | NA | NA | |
NA | ₹11.10 Cr | 16.72% | 0.52 | -₹1 Cr | NA | |
NA | ₹5,613.89 Cr | 345.75% | 0.50 | ₹174 Cr | ₹958 Cr | |
NA | ₹778.65 Cr | 208.88% | 0.71 | ₹5 Cr | ₹249 Cr | |
NA | ₹119.57 Cr | 172.94% | 0.56 | NA | NA |
Organisation | Remedium Lifecare Ltd |
Headquarters | Ludhiana |
Industry | Trading |
E-voting on shares | Click here to vote |
Key events for Remedium Lifecare Ltd
Remedium Lifecare shares are in high demand, trading below Rs 10 after a recent face value split and bonus issue. The stock has delivered over 3,100% returns in five years, despite a 76% correction in the last year. It commands a market cap of Rs 259.66 crore.
Remedium Lifecare Expands Globally Amid Stock Surge - 22 Oct, 2024
Remedium Lifecare Ltd's shares surged 5% to Rs 6.95 as the company expands globally with a new subsidiary in Singapore and plans for major acquisitions. The firm aims to raise USD 25 million for growth initiatives and has reported impressive financial performance, including a 698% income increase for FY24.
Remedium Lifecare Expands with Singapore Subsidiary - 08 Oct, 2024
Remedium Lifecare has established a wholly-owned subsidiary in Singapore, REMLIFE GLOBAL PTE. LTD., to support its international growth strategy and potential acquisitions.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Promoter Holding Unchanged
Promoters holdings remained unchanged at 1.11% of holdings in Sep 2024 quarter
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 98.89% of holdings in Sep 2024 quarter
Price Dip
In the last 7 days, Remedium Life stock has moved down by -5.7%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 1.11% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 98.89% | 0.00 | |
Others | 0% | 0.00 |
Remedium Lifecare Ltd’s net profit fell -72.74% since last year same period to ₹1.78Cr in the Q2 2024-2025. On a quarterly growth basis, Remedium Lifecare Ltd has generated 8.54% jump in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Remedium Lifecare Ltd is currently in a Bearish trading position according to technical analysis indicators.
Remedium Lifecare Ltd (539561) share price today is ₹5.95
Remedium Lifecare Ltd is not listed on NSE
Remedium Lifecare Ltd is listed on BSE
Today’s traded volume of Remedium Lifecare Ltd(539561) is 1.35L.
Today’s market capitalisation of Remedium Lifecare Ltd(539561) is ₹244.74Cr.
Remedium Lifecare Ltd(539561 | Price |
---|---|
52 Week High | ₹38.25 |
52 Week Low | ₹5.29 |
Remedium Lifecare Ltd(539561) share price is ₹5.95. It is down -84.44% from its 52 Week High price of ₹38.25
Remedium Lifecare Ltd(539561) share price is ₹5.95. It is up 12.48% from its 52 Week Low price of ₹5.29
Remedium Lifecare Ltd(539561 | Returns |
---|---|
1 Day Returns | -0.12% |
1 Month Returns | -4.49% |
3 Month Returns | -40.08% |
1 Year Returns | -76.49% |